Essential thrombocythemia (ET) is a myeloproliferative disorder charac
terized by persistent elevation in platelet count. It is a rare disord
er in children, and children who have symptoms require treatment. We r
eport the successful use of anagrelide, with few toxic effects, in the
treatment of three children with ET.